Q9UBN6 (TR10D_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 122.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Tumor necrosis factor receptor superfamily member 10D Alternative name(s): Decoy receptor 2 Short name=DcR2 TNF-related apoptosis-inducing ligand receptor 4 Short name=TRAIL receptor 4 Short name=TRAIL-R4 TRAIL receptor with a truncated death domain CD_antigen=CD264 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 386 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor for the cytotoxic ligand TRAIL. Contains a truncated death domain and hence is not capable of inducing apoptosis but protects against TRAIL-mediated apoptosis. Reports are contradictory with regards to its ability to induce the NF-kappa-B pathway. According to Ref.1, it cannot but according to Ref.2, it can induce the NF-kappa-B pathway. |
| Subcellular location | |
| Tissue specificity | Widely expressed, in particular in fetal kidney, lung and liver, and in adult testis and liver. Also expressed in peripheral blood leukocytes, colon and small intestine, ovary, prostate, thymus, spleen, pancreas, kidney, lung, placenta and heart. |
| Sequence similarities | Contains 1 death domain. Contains 3 TNFR-Cys repeats. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Apoptosis |
| Cellular component | Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | Repeat Signal Transmembrane Transmembrane helix |
| Molecular function | Receptor |
| PTM | Disulfide bond Glycoprotein |
| Technical term | Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | apoptotic process Inferred from electronic annotation. Source: UniProtKB-KW negative regulation of apoptotic processTraceable author statement Ref.2. Source: ProtInc |
| Cellular_component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW |
| Molecular_function | transmembrane signaling receptor activity Traceable author statement Ref.2. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 55 | 55 | Ref.1 Ref.7 | ||||||||
| Chain | 56 – 386 | 331 | Tumor necrosis factor receptor superfamily member 10D | PRO_0000034584 | |||||||
Regions | |||||||||||
| Topological domain | 56 – 211 | 156 | Extracellular Potential | ||||||||
| Transmembrane | 212 – 232 | 21 | Helical; Potential | ||||||||
| Topological domain | 233 – 386 | 154 | Cytoplasmic Potential | ||||||||
| Repeat | 58 – 97 | 40 | TNFR-Cys 1 | ||||||||
| Repeat | 98 – 139 | 42 | TNFR-Cys 2 | ||||||||
| Repeat | 140 – 180 | 41 | TNFR-Cys 3 | ||||||||
| Domain | 340 – 366 | 27 | Death; truncated | ||||||||
| Compositional bias | 225 – 228 | 4 | Poly-Val | ||||||||
| Compositional bias | 246 – 250 | 5 | Poly-Gly | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 127 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 182 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 83 ↔ 96 | By similarity | |||||||||
| Disulfide bond | 99 ↔ 115 | By similarity | |||||||||
| Disulfide bond | 118 ↔ 131 | By similarity | |||||||||
| Disulfide bond | 121 ↔ 139 | By similarity | |||||||||
| Disulfide bond | 141 ↔ 155 | By similarity | |||||||||
| Disulfide bond | 158 ↔ 172 | By similarity | |||||||||
| Disulfide bond | 162 ↔ 180 | By similarity | |||||||||
Natural variations | |||||||||||
| Natural variant | 35 | 1 | P → S in TRAIL-R4-B. Ref.2 Corresponds to variant rs11135703 [ dbSNP | Ensembl ]. | VAR_011417 | |||||||
| Natural variant | 276 | 1 | R → H. Corresponds to variant rs55636833 [ dbSNP | Ensembl ]. | VAR_061854 | |||||||
| Natural variant | 310 | 1 | S → L in TRAIL-R4-B. Ref.2 Corresponds to variant rs1133782 [ dbSNP | Ensembl ]. | VAR_011418 | |||||||
| Natural variant | 345 | 1 | T → P. Corresponds to variant rs34622674 [ dbSNP | Ensembl ]. | VAR_057288 | |||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A novel receptor for Apo2L/TRAIL contains a truncated death domain." Marsters S.A., Sheridan J.P., Pitti R.M., Huang A., Skubatch M., Baldwin D., Yuan J., Gurney A., Goddard A.D., Godowski P., Ashkenazi A. Curr. Biol. 7:1003-1006(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF N-TERMINUS. Tissue: Fetal lung. |
| [2] | "The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain." Degli-Esposti M.A., Dougall W.C., Smolak P.J., Waugh J.Y., Smith C.A., Goodwin R.G. Immunity 7:813-820(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, VARIANTS SER-35 AND LEU-310. Tissue: Foreskin fibroblast and Peripheral blood lymphocyte. |
| [3] | "TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling." Pan G., Ni J., Yu G.-L., Wei Y.-F., Dixit V.M. FEBS Lett. 424:41-45(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION. |
| [4] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Prostate. |
| [7] | "Signal peptide prediction based on analysis of experimentally verified cleavage sites." Zhang Z., Henzel W.J. Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 56-70. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF029761 mRNA. Translation: AAD03477.1. AF021232 mRNA. Translation: AAC32765.1. AF021233 mRNA. Translation: AAC32766.1. AF023849 mRNA. Translation: AAC52053.1. AY358285 mRNA. Translation: AAQ88652.1. AK313528 mRNA. Translation: BAG36307.1. BC052270 mRNA. Translation: AAH52270.1. |
| IPI | IPI00294516. |
| RefSeq | NP_003831.2. NM_003840.4. |
| UniGene | Hs.213467. |
3D structure databases | |
| ProteinModelPortal | Q9UBN6. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-6231N. |
| IntAct | Q9UBN6. 1 interaction. |
| STRING | 9606.ENSP00000310263. |
PTM databases | |
| PhosphoSite | Q9UBN6. |
Polymorphism databases | |
| DMDM | 18203495. |
Proteomic databases | |
| PaxDb | Q9UBN6. |
| PRIDE | Q9UBN6. |
Protocols and materials databases | |
| DNASU | 8793. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000312584; ENSP00000310263; ENSG00000173530. |
| GeneID | 8793. |
| KEGG | hsa:8793. |
| UCSC | uc003xcz.1. human. |
Organism-specific databases | |
| CTD | 8793. |
| GeneCards | GC08M022993. |
| H-InvDB | HIX0025539. |
| HGNC | HGNC:11907. TNFRSF10D. |
| MIM | 603614. gene. |
| neXtProt | NX_Q9UBN6. |
| PharmGKB | PA36600. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG80202. |
| HOGENOM | HOG000142423. |
| HOVERGEN | HBG061626. |
| InParanoid | Q9UBN6. |
| KO | K04722. |
| OrthoDB | EOG42821W. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | trail_pathway. TRAIL signaling pathway. |
Gene expression databases | |
| Bgee | Q9UBN6. |
| CleanEx | HS_TNFRSF10D. |
| Genevestigator | Q9UBN6. |
| GermOnline | ENSG00000173530. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR001368. TNFR/NGFR_Cys_rich_reg. IPR020465. TNFR_10. [Graphical view] |
| Pfam | PF00020. TNFR_c6. 2 hits. [Graphical view] |
| PRINTS | PR01956. TNFACTORR10. |
| SMART | SM00208. TNFR. 2 hits. [Graphical view] |
| PROSITE | PS50017. DEATH_DOMAIN. False negative. PS00652. TNFR_NGFR_1. 2 hits. PS50050. TNFR_NGFR_2. 2 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 8793. |
| NextBio | 32976. |
| SOURCE | Search... |
Entry information
| Entry name | TR10D_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UBN6 Secondary accession number(s): B2R8W0, Q9Y6Q4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
